ArticleCritical care explorations2019

A Pilot Study on Continuous Infusion of 4% Albumin in Critically Ill Patients: Impact on Nosocomial Infection via a Reduction Mechanism for Oxidized Substrates.

Francis Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.